Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation
The amphetamine analogue 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') is widely abused as a recreational drug due to its unique psychological effects. Of interest, MDMA causes long-lasting deficits in neurochemical and histological markers of the serotonergic neurons in the brain of...
Saved in:
Main Authors: | Elena Puerta (Author), Norberto Aguirre (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2011-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
3,4-methylenedioxymethamphetamine (MDMA): current perspectives
by: Meyer JS
Published: (2013) -
Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the Literature
by: Guillaume Drevin, et al.
Published: (2024) -
The use of 3,4-Methylenedioxymethamphetamine (MDMA) in the treatment of Post-Traumatic Stress Disorder (PTSD) - review
by: Karol Womperski, et al.
Published: (2023) -
Differential sensitivity to detect prosocial effects of 3,4‐methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice
by: Satoko Mukai, et al.
Published: (2020) -
Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand
by: Jai Whelan, et al.
Published: (2024)